Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$21.53 USD
+0.43 (2.01%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $21.54 +0.01 (0.05%) 6:14 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 31% (77 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.54 | 1.35 | 9.99 |
Current Quarter Estimate | -1.34 | 7.43 | 60.00 |
Year Ago Quarter Estimate | -1.17 | 0.12 | 52.54 |
Next Quarter Estimate | -1.34 | 7.81 | 61.00 |
Next Year Estimate | -5.54 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -2.95 | 13.00 | 17.08 |
Next Year | 0.72 | 7.90 | 8.00 |
Last 5 Years | -288.60 | 1.00 | 8.10 |
Next 5 Years | 29.30 | 20.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 1.86 | 2.01 |
Price/Cash Flow (MRFY) | NA | 14.08 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -893.34% | -100.99% |
Return on Equity (TTM) | -43.91% | -55.59% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.